Learn More
Lkt Laboratories CAS 88899-55-2, ≥90%, Vacuolar H+ ATPase inhibitor. It suppresses autophagy, prevents tumor growth in breast cancer models, and inhibits growth of Plasmodium.

Supplier: Lkt Laboratories B0025

Bafilomycin A1 is a macrolide antibiotic initially produced by Streptomyces that exhibits anti-parasitic, antimalarial, and anticancer chemotherapeutic activities. Bafilomycin A1 inhibits the vacuolar H+ ATPase and suppresses autophagy. Bafilomycin kills Plasmodium parasites in cellular models, and separately, induces cell death and suppresses tumor growth in animal models of breast cancer.
The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.